|
RYTM Rhythm Pharmaceuticals Inc 1649904 |
| Balance Sheet |
|
Current Assets
|
$430,090,000.00 |
|
Assets
|
$442,316,000.00 |
|
Current Liabilities
|
$103,198,000.00 |
|
Liabilities
|
$204,700,000.00 |
|
Equity
|
$122,906,000.00 |
|
Shares Out
|
68445084.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-44,185,000.00 |
|
Investing Cash Flow
|
$57,052,000.00 |
| Market Analysis |
Market Cap
|
$7,237,383,182.16 |
|
Price
|
$98.62 |
|
BVPS
|
1.80 |
|
PB
|
58.74 |
|
EPS
|
-0.83 |
|
PS
|
32.50 |
|
FCF
|
$-45,138,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:18 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:12 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.73 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-05 |
-0.83 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.75 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.82 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RYTM documents filed with the SEC.
RYTM Filings
Clear
